Palbociclib in advanced breast cancer: A cost-utility analysis

被引：0
|
作者：
Raphael, J. [1 ]
Helou, J. [1 ]
Naimark, D. M. [1 ]
机构：
[1] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1116P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients
    Xu, Xian
    Ma, Ying-Yan
    Zou, Hai-Dong
    JOURNAL OF GLAUCOMA, 2016, 25 (07) : E657 - E662
  • [32] Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis
    Umberto Cillo
    Gaya Spolverato
    Alessandro Vitale
    Aslam Ejaz
    Sara Lonardi
    David Cosgrove
    Timothy M. Pawlik
    World Journal of Surgery, 2015, 39 : 2500 - 2509
  • [33] Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis
    Cillo, Umberto
    Spolverato, Gaya
    Vitale, Alessandro
    Ejaz, Aslam
    Lonardi, Sara
    Cosgrove, David
    Pawlik, Timothy M.
    WORLD JOURNAL OF SURGERY, 2015, 39 (10) : 2500 - 2509
  • [34] Cost-utility analysis of adjuvant Goserelin and adjuvant chemotherapy in patients with premenopausal breast cancer
    Cheng, T. F.
    VALUE IN HEALTH, 2008, 11 (03) : A71 - A71
  • [35] Interpreting cost-utility analysis of prostate cancer treatment
    James B. Yu
    Nature Reviews Urology, 2013, 10 : 129 - 131
  • [36] A Cost-Utility Analysis of Prostate Cancer Screening in Australia
    Keller, Andrew
    Gericke, Christian
    Whitty, Jennifer A.
    Yaxley, John
    Kua, Boon
    Coughlin, Geoff
    Gianduzzo, Troy
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (01) : 95 - 111
  • [37] Interpreting cost-utility analysis of prostate cancer treatment
    Yu, James B.
    NATURE REVIEWS UROLOGY, 2013, 10 (03) : 129 - 131
  • [38] A Cost-Utility Analysis of Prostate Cancer Screening in Australia
    Andrew Keller
    Christian Gericke
    Jennifer A. Whitty
    John Yaxley
    Boon Kua
    Geoff Coughlin
    Troy Gianduzzo
    Applied Health Economics and Health Policy, 2017, 15 : 95 - 111
  • [39] Cost-Utility of the CDK 4/6 Inhibitors for Postmenopausal Women With Luminal Advanced Breast Cancer in Brazil
    Damico Nascimento Macedo, Luana Schroeder
    Silva, Aline Silveira
    Wekmuller Franca, Ana Claudia
    da Silva Magliano, Carlos Alberto
    Meirelles, Isandra
    Padilla, Matheus Piccin
    Santos, Marisa da Silva
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 31 : 47 - 52
  • [40] COST-UTILITY ANALYSIS IN UROLOGY
    Fero, Katherine
    Sharma, Vidit
    Lec, Patrick
    Saigal, Christopher
    Chamie, Karim
    JOURNAL OF UROLOGY, 2021, 206 : E435 - E436
12345